Commentary: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Detalles Bibliográficos
Autores principales: Djomkam, Alexandra Lindsey Zune, Olwal, Charles Ochieng', Sala, Theodore Beyeme, Paemka, Lily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466403/
https://www.ncbi.nlm.nih.gov/pubmed/32974166
http://dx.doi.org/10.3389/fonc.2020.01448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466403/
https://www.ncbi.nlm.nih.gov/pubmed/32974166
http://dx.doi.org/10.3389/fonc.2020.01448

Ejemplares similares